Back

Unlocking viral evasion: Luminal charge interactions in BoHV-1 UL49.5 allosterically control TAP degradation

Karska, N.; Graul, M.; Zhukov, I.; Rodziewicz-Motowidlo, S.; Lipinska, A. D.; Slusarz, M. J.

2026-06-12 biochemistry
10.64898/2026.06.11.731699 bioRxiv
Show abstract

The UL49.5 protein of bovine alphaherpesvirus 1 (BoHV-1) is known to inhibit the transporter associated with antigen processing (TAP) and interfere with antigen presentation, in part by promoting TAP degradation. However, the role of electrostatic interactions within the N-terminal luminal domain in controlling these processes remains unclear. Here, we combined circular dichroism (CD), solution nuclear magnetic resonance spectroscopy (NMR), all-atom molecular dynamics simulations, and cell-based assays to define the structural and functional contribution of charged residues within the N-terminal luminal domain of UL49.5. Two N-terminal variants of UL49.5, UL49.522-56RR(30-31)DD and UL49.522-56D36K, with substitutions of charged-reversal amino acid residues, were designed. These two mutants formed membrane-induced -helical structures but showed altered helix stability and interaction patterns. Molecular dynamics simulations of the UL49.5-TAP complexes revealed that wild-type UL49.5 forms a stable electrostatic interface with TAP, particularly in the unkinked conformation, while charge-reversal mutations remodel salt-bridge networks, destabilize the luminal helix, and alter the positioning and dynamics of the transmembrane and cytoplasmic C-terminal regions. The structural changes within the N-terminus alter the exposure of the C-terminal degron required for KLHDC3-dependent degradation. Consistent with these findings, the mutants did not induce proteasomal degradation of TAP, despite maintaining near wild-type levels of downregulation of MHC class I. Together, these results identify N-terminal electrostatic interactions as allosteric determinants of UL49.5-driven TAP degradation and demonstrate that TAP degradation can be mechanically uncoupled from downregulation of MHC class I. This study improves our understanding of viral immune evasion strategies and potential therapeutic targets.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Journal of Virology
499 papers in training set
Top 0.3%
26.2%
2
Journal of Biological Chemistry
690 papers in training set
Top 0.4%
14.9%
3
PLOS Pathogens
820 papers in training set
Top 1%
11.7%
50% of probability mass above
4
Biophysical Journal
631 papers in training set
Top 2%
4.0%
5
Protein Science
246 papers in training set
Top 1%
4.0%
6
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 14%
4.0%
7
eLife
5828 papers in training set
Top 32%
3.4%
8
mBio
833 papers in training set
Top 6%
2.4%
9
PLOS ONE
5266 papers in training set
Top 43%
2.4%
10
Biochemistry
148 papers in training set
Top 1%
2.1%
11
Cell Reports
1498 papers in training set
Top 18%
1.9%
12
Nature Communications
5641 papers in training set
Top 44%
1.9%
13
Nucleic Acids Research
1281 papers in training set
Top 9%
1.7%
14
Scientific Reports
3612 papers in training set
Top 59%
1.5%
15
Journal of Proteome Research
234 papers in training set
Top 1%
1.4%
16
Journal of Molecular Biology
232 papers in training set
Top 3%
1.1%
17
Viruses
332 papers in training set
Top 4%
1.1%
18
Communications Biology
993 papers in training set
Top 22%
1.1%
19
Biochemical Journal
91 papers in training set
Top 1%
1.0%
20
mSphere
302 papers in training set
Top 7%
0.8%
21
Virology
61 papers in training set
Top 1%
0.8%
22
The FEBS Journal
93 papers in training set
Top 2%
0.8%
23
ACS Chemical Biology
167 papers in training set
Top 3%
0.6%